Unlike injectable GLP-1 medications, Oral Semaglutide is taken as a daily tablet, making it an excellent option for patients who prefer to avoid injections
Metabolic Support: Peptide therapy with CJC 1295 Ipamorelin can enhance metabolism by increasing energy expenditure, promoting fat loss, and preserving lean muscle mass, leading to improvements in body composition and metabolic health
Unlike Ozempic (which is a GLP-1 receptor agonist), Zepbound targets both GLP-1 and GIP receptors
When clinically appropriate, compounded formulations can also be less expensive than name-brand products, lowering out-of-pocket costs
Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study investigator Edy Kornelius, M.D., Ph.D., of Chung Shan Medical University in Taichung, Taiwan
Cukierman-Yaffe, T., et al